株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

細菌性(化膿性)髄膜炎:世界の治験レビュー

Bacterial (Pyogenic) Meningitis Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 247623
出版日 ページ情報 英文 100 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。
Back to Top
細菌性(化膿性)髄膜炎:世界の治験レビュー Bacterial (Pyogenic) Meningitis Global Clinical Trials Review, H2, 2014
出版日: 2014年11月17日 ページ情報: 英文 100 Pages
概要

当レポートでは、細菌性(化膿性)髄膜炎に関する臨床研究の最新動向について分析し、疾患・治療法の概要や、G7諸国における治験の状況、地域・フェーズ(相)・段階別の進行状況、有望なスポンサー、各企業・研究機関での研究の進行状況、有望な薬剤の比較といった情報を盛り込んで、お届けします。

イントロダクション

  • 細菌性(化膿性)髄膜炎
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • 上位5ヶ国における治験件数; アジア太平洋地域
    • 上位5ヶ国における治験件数; 欧州
    • 主要国における治験件数; 北米
    • 上位5ヶ国における治験件数; 中東/アフリカ地域
    • 上位5ヶ国における治験件数; 中南米

G7諸国における治験件数: 細菌性(化膿性)髄膜炎治験件数の感染症治験件数に対する比率

フェーズ(相)別治験件数: G7諸国

G7諸国における治験件数:フェーズ(相)別

E7諸国における治験件数: 細菌性(化膿性)髄膜炎治験件数の感染症治験件数に対する比率

フェーズ(相)別治験件数: E7諸国

E7諸国における治験件数:フェーズ(相)別

フェーズ(相)別治験件数

  • フェーズ(相)別の進行中治験件数

進捗状況別の治験件数

評価項目別の治験件数

未完了の治験 細菌性(化膿性)髄膜炎

一定期間に採用された被験者数

スポンサーの種類別の治験件数

有望なスポンサー

治験主要参加企業 - 細菌性(化膿性)髄膜炎治療薬

有望な薬剤

治験のプロファイル

  • 代表的な企業の治験の概要
    • Novartis AG
    • Pfizer Inc.
    • GlaxoSmithKline plc
    • Sanofi
    • Serum Institute of India Limited
    • Baxter International Inc.
    • JN-International Medical Corporation
    • Beijing Minhai Biotechnology Co., Ltd
    • Abbott Laboratories
  • 代表的な研究機関/病院の治験の概要
    • University of Oxford
    • Assistance Publique - Hopitaux de Paris
    • Universitas Padjadjaran
    • Chhatrapati Shahuji Maharaj Medical University
    • Health Protection Agency
    • The National Institute of Allergy and Infectious Diseases
    • Bio-Manguinhos
    • University of Malawi
    • National Institute for Public Health and the Environment
    • Epicentre Biotechnologies

5大治験プロファイル

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC2419CTIDB

GlobalData's clinical trial report, "Bacterial (Pyogenic) Meningitis Global Clinical Trials Review, H2, 2014" provides data on the Bacterial (Pyogenic) Meningitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bacterial (Pyogenic) Meningitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bacterial (Pyogenic) Meningitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Bacterial (Pyogenic) Meningitis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Bacterial (Pyogenic) Meningitis to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Bacterial (Pyogenic) Meningitis to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Bacterial (Pyogenic) Meningitis
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Serum Institute of India Limited
      • Clinical Trial Overview of Serum Institute of India Limited
      • Baxter International Inc.
      • Clinical Trial Overview of Baxter International Inc.
      • JN-International Medical Corporation
      • Clinical Trial Overview of JN-International Medical Corporation
      • Beijing Minhai Biotechnology Co., Ltd
      • Clinical Trial Overview of Beijing Minhai Biotechnology Co., Ltd
      • Abbott Laboratories
      • Clinical Trial Overview of Abbott Laboratories
    • Clinical Trial Overview of Top Institutes / Government
      • University of Oxford
      • Clinical Trial Overview of University of Oxford
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
      • Universitas Padjadjaran
      • Clinical Trial Overview of Universitas Padjadjaran
      • Chhatrapati Shahuji Maharaj Medical University
      • Clinical Trial Overview of Chhatrapati Shahuji Maharaj Medical University
      • Health Protection Agency
      • Clinical Trial Overview of Health Protection Agency
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • Bio-Manguinhos
      • Clinical Trial Overview of Bio-Manguinhos
      • University of Malawi
      • Clinical Trial Overview of University of Malawi
      • National Institute for Public Health and the Environment
      • Clinical Trial Overview of National Institute for Public Health and the Environment
      • Epicentre Biotechnologies
      • Clinical Trial Overview of Epicentre Biotechnologies
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Bacterial (Pyogenic) Meningitis Therapeutics, Global, Clinical Trials by Region, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Bacterial (Pyogenic) Meningitis to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Bacterial (Pyogenic) Meningitis to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Bacterial (Pyogenic) Meningitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Serum Institute of India Limited, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by JN-International Medical Corporation, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Beijing Minhai Biotechnology Co., Ltd, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Universitas Padjadjaran, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Chhatrapati Shahuji Maharaj Medical University, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Health Protection Agency, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bio-Manguinhos, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Malawi, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute for Public Health and the Environment, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Epicentre Biotechnologies, 2014*

List of Figures

  • Bacterial (Pyogenic) Meningitis Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Bacterial (Pyogenic) Meningitis to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Bacterial (Pyogenic) Meningitis to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Bacterial (Pyogenic) Meningitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top